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Cutaneous anthrax patients in Eastern Anatolia,
Turkey: a review of 44 adults cases

Kemalettin ÖZDEN1, Zülal ÖZKURT1, Serpil EROL1, Muhammet Hamidullah UYANIK2,
Mehmet PARLAK1

Aim: Anthrax is a zoonotic infectious disease caused by B. anthracis. It remains as an important issue in developing
countries and it is a potential threat for the world because of its use as a biological weapon. In this study, we evaluated
the epidemiological, clinical, and laboratory characteristics of 44 patients with cutaneous anthrax in our region.
Materials and methods: The study included 44 cutaneous anthrax patients admitted to our hospital from the Eastern
Anatolia Region of Turkey between 2005 and 2008.
Results: Out of 44 cases, 24 (54.5%) were male and 20 (45.5%) female. The mean age was 41 ± 14.96 years. High risk
occupations were farmers (n = 21, 48%) and housewives (n = 19, 43%). The sample consisted of 33 (75%) cutaneous
anthrax with pustular lesion and 11 (25%) severe cutaneous anthrax with extensive edema. The most common exposures
to sick animal or animal products were cutting of meat (n = 36, 81.8%), slaughtering of animal (n = 34, 77.3%), and
direct contact with sick animal (n = 22, 50%). Cutaneous lesions were commonly located on hands (n = 24, 54.5%), arms
(18, 40.9%), and fingers (n = 11, 25%). No death occurred and all of them were discharged from hospital.
Conclusion: Anthrax is still an important health issue in Turkey and usually presents as a cutaneous anthrax. Cutaneous
anthrax should be considered in any patient with a painless ulcer with vesicles, edema, and a history of exposure to
animals or animal products. The people under risk should be informed about risky exposures. Vaccination of animals
may decrease the number of animal and human anthrax cases.
Key words: Bacillus anthracis, anthrax, cutaneous anthrax

Doğu Anadolu bölgesinde 44 deri şarbonu olgusunun değerlendirilmesi
Amaç: Şarbon B. anthracis tarafından oluşturulan zoonotik bir enfeksiyon hastalığıdır. Gelişmekte olan ülkelerde
hala önemini korumaktadır. Biyolojik silah olarak kullanılmaya uygun olması, tüm dünya için potansiyel bir tehdit
oluşturmaktadır. Biz bu çalışmamızda bölgemizde görülen deri şarbonu olan olgularının epidemiyolojik, klinik ve
laboratuar özelliklerini irdelemek.
Yöntem ve gereç: Çalışmamız, 2005-2008 yılları arasında Doğu Anadolu bölgesinden hastanemize başvuran ve
yatırılarak tedavileri yapılan 44 deri şarbonu olgusunu içermektedir.
Bulgular: Çalışmamız kapsamındaki 44 deri şarbonu olgusunun 24’ü (% 54,5) erkek, 20’si (% 45,5) kadındı. Hastaların
yaş ortalaması 41 ± 14.96 olarak bulundu. Mesleki açıdan en yüksek risk grubu çiftçiler (n = 21, % 48) ve ev hanımlarıydı
(n = 19, % 43). Olguların 33’ü (% 75) hafif püstüler şarbon lezyonu, 11’i (% 25) ise ağır deri şarbonu ve yaygın ödemi
bulunan hastalardan meydana gelmişti. Riskli temasların sıklıkla hayvanın etinin doğranması (n = 36, % 81,8), hayvan
Received: 29.03.2011 – Accepted: 22.06.2011
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Atatürk University, Erzurum - TURKEY
2
Department of Microbiology and Clinical Microbiology, Faculty of Medicine, Atatürk University, Erzurum – TURKEY
Correspondence: Kemalettin ÖZDEN, Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Atatürk University, Erzurum - TURKEY
E-mail: drkemalozden@gmail.com
1

39

Cutaneous anthrax patients in eastern Anatolia, Turkey

kesimi (n = 34, % 77,3) ve hasta hayvanla direkt temas (n = 22, % 50) şeklinde oluştuğu tespit edildi. Cilt lezyonlarının en
sık eller (n = 24, % 54,5), kollar (n = 18, % 40,9) ve parmaklarda (n = 11, % 25) lokalize olduğu belirlendi. Olgularımızın
hiçbiri ölümle sonuçlanmadı, tamamı şifa ile taburcu edildi.
Sonuç: Şarbon ülkemiz için hala önemli bir sağlık sorunudur ve genellikle deri şarbonu şeklinde karşımıza çıkmaktadır.
Hasta bir hayvan ya da hayvan ürünüyle temas öyküsü olan ve ödem, vezikül ile birlikte ağrısız ülseri bulunan bir kişide
şarbon akla gelmelidir. Risk grubunda bulunan kişiler bulaş ve riskli davranışlar açısından eğitilmelidir. Hayvanların
aşılanması, hem hayvan hem de insan şarbon olgularını azaltabilecektir.
Anahtar sözcükler: Bacillus anthracis, şarbon, deri şarbonu

Introduction

Materials and methods

Bacillus anthracis, the etiological agent of anthrax,
is a Gram-positive, aerobic or facultatively anaerobic,
spore-forming, rod-shaped bacterium (1-3).
Although anthrax has gradually reduced throughout
the world, it has not been completely eradicated.
Human is an incidental host and infected as a result
of direct or indirect contact with contaminated
animals or animal products (4). Anthrax has 3 major
transmission channels to humans: inhalational,
gastrointestinal, and cutaneous. Cutaneous anthrax
is the most common form of naturally occurring
anthrax and consists of approximately 95% of all
cases of anthrax (4,5). In cutaneous anthrax, the
organism’s portal of entry is a cut or an abrasion on
the skin. The areas at the greatest risk of exposure are
hands, arms, face, and the neck.

The adult patients, who admitted to the Infectious
Disease Clinic of Atatürk University Faculty of
Medicine between January 2005 and December
2008, with the suspicion of cutaneous anthrax, were
included in the study. The records of the patients
were reviewed, and data on age, gender, occupation,
clinical symptoms and findings, location and type of
lesions, clinical history, laboratory findings including
the white blood cell (WBC), peripheral blood smear,
blood biochemistry and C-reactive protein, were
recorded.

Although anthrax is a rarely encountered disease in
the United States of America, it is a relatively common
infectious disease in the Middle East, Central Asia,
and Africa. Anthrax cases are found in some parts
of Europe, especially in Mediterranean countries,
such as Spain, Greece, and Turkey (1,5,6). Anthrax
has gradually reduced in Turkey over the years, but
it is still an endemic infectious disease. In Turkey,
from 1960 to 1969, 10,724 cases of human anthrax
have been reported. The numbers of reported cases
were 4423, 4220, and 2210 between 1980 and 1989,
between 1990 and 1999, and between 2000 and 2005,
respectively. According to the report of the Ministry
of Health, 262 human cases were reported in 2007,
126 in 2008 and 132 in 2009 in Turkey (5,7,8).
In this study, we evaluated the clinical history and
features, treatment, and outcome of 44 patients with
cutaneous anthrax followed up in our clinic over a
4-year period between 2005 and 2008.
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The clinical finding was a typical anthrax skin
lesion (an ulcer covered by a characteristic black
eschar) in a patient with appropriate history. The
detailed medical history included the occupation
of the patient, exposure to sick animals or animal
products, and the time of onset of the first
lesion. Microbiological diagnosis was based on
demonstration of Gram-positive bacilli from a lesion,
and/or isolation of B. anthracis after bacteriological
culture. Clinical material was obtained with needle
aspiration from vesicle in the vesicular stage and with
sterile swab under an eschar during the eschar stage.
Obtained clinical specimens were inoculated onto
blood agar and incubated for 24 h at 37 °C under
aerobic conditions. In the case of non-hemolytic,
fairly flat, 2-7 mm diameter, white or gray-white
colonies with irregular edges were observed, the
grown bacteria were identified by conventional
methods. To this end, Gram-stain, motility agar and
catalase activity were used.
Results
The study included 44 patients with cutaneous
anthrax, 24 (54.5%) were male and 20 (45.5%) female.

The mean age was 41 ± 14.96 years (min:16-max:67).
High risk occupations for anthrax were farmers
(48%) and housewives (43%). The distribution of the
patients by their occupation is shown in Figure 1.
Occupational risk factors
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Figure 3. Monthly distribution of the cases.
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Figure 1. Occupational risk factors.

Almost all of the patients who admitted to our
hospital were from the rural area of eastern Anatolia,
mainly from Erzurum and Kars cities. Although there
were cases of anthrax throughout the year, it peaked
especially in August (22.7%) and September (38.6%).
The incidence of the disease was similar between
2005 and 2007; however, its frequency increased in
2008 (Figures 2 and 3).

Figure 4. Cutaneous anthrax lesion with extensive edema on the
face.
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Figure 5. Edema and hemorrhagic bullae on the arm.
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Figure 2. Annual distribution of the patients.

All of the patients who were admitted to our clinic
were cutaneous anthrax. Of cutaneous lesions, 11
(25%) were severe cutaneous anthrax with extensive
edema and 33 (75%) cutaneous anthrax with a typical
pustular lesion (Figures 4 and 5).

In all patients, there was a contact history either
with a sick animal (cattle, sheep), or an animal
product except for 2 cases (4.5%), both were farmers
and living in a rural area. One of these patients, who
had no known contact history, had told that when he
went outside of his home to drink water in a fountain,
a bird dropped a piece of meat into the water and he
removed it with his hand. He also told us an acnelike lesion appeared on his face on the day after the
41
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incident occurred and later his face got swollen. The
other patient had no history of direct contact with
sick animals and animal products; however, he was
living in a rural area and busy with farming. Thus
he was likely to contact with contaminated soil.
Risky contacts in the patients were cutting of meat
(81.8%), slaughtering (77.3%), contact with sick
animals (50.0%), skinning (15.9%), and carrying
contaminated animal products (11.4%) (Table 1).
Some patients had a history of multiple contacts.
Table 1. Types of animal contact.
n = 44

%*

Cutting of meat

36

81.8

Slaughtering

34

77.3

Skin peeling

7

15.9

Carrying contaminated packet

5

11.4

Contact with sick animals

22

50.0

* A case may have more than one contact history

Some patients had lesions in more than one
region. Their lesions were located in hands (54.5%),
arms (40.9%), fingers (25.0%), face (11.4%), neck
(9.1%), lips and surrounding area (6.8%), and eyelids
(6.8%). Out of the patients, 11 (25.0%) had lesions
in 2 different areas and 5 (11.4%) in 3 different areas
(Table 2). Diagnosis was mainly based on the typical
skin lesion and the history of the patients cases. Only
5 patients had positive culture result for Bacillus
anthracis.
Table 2. Sites of the lesions.

Their treatments were tailored according to the
clinical and laboratory results and also the location
and extent of the lesions. In severe cases with
extensive edema, crystallized penicillin G (20-24
million IU/day) IV, in mild cases procaine penicillin
G (800,000 IU bid) intramuscularly, and in cases
with small lesions oral amoxicillin (1000 mg tid) was
the preferred treatment option. In addition to the
antibiotic treatment, 1 mg/kg per day prednisolone
was given in most of the cases with extensive edema
and some cases of malignant pustule. Mean treatment
duration was 9 and 9.3 days in cases with malignant
pustule and with extensive edema, respectively.
The average incubation period of the disease
was 4.2 ± 3.6 days (range, 1-11 days). None of the
patients followed in our department developed
any complications, such as sepsis or respiratory
obstruction, and all were discharged from hospital
with cure. The symptoms, and clinical and laboratory
data of the patients are shown in Table 3. CRP was
within normal limits only in 2 patients (4.5%). In
the remaining 42 patients (95.5%), it was higher than
normal ranges (>5 mg/L). The average CRP level
was 63.2 ± 64.6. The number of WBC in 15 patients
(34.1%) was within normal limits, and in 29 patients
Table 3. Clinical and laboratory findings.
n

%

Age
<18
≥18

3
41

6,8
93.2

Female

20

45.5

Male

24

54.5

Black eschar formation

44

100

n

%

Finger

11

25.0

Swelling

44

100

Hand

24

54.5

Erythema

44

100

Arm

18

40.9

Pain

13

29.5

Eyelids

3

6.8

Pruritis

21

47.7

Lips and surrounding area

3

6.8

Fever

8

18.2

Neck

4

9.1

Face

5

11.4

Laboratory findings
WBC > 10.000/mm3
(normal range 4-109 cells/L)
CRP > 5 mg/L (normal range < 5 mg/L)

29

65.9

42

95.5

* A case may have more than one lesion.
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(65.9%) was higher than normal levels (>10.000/
mm3). The mean WBC levels were found to be 14.142
± 7.486.
Discussion
Anthrax has been eradicated in developed
countries; however, it still remains a major public
health problem in many developing countries. Its
suitability for use as a biological weapon has increased
its importance and popularity. In developed countries,
there is also a risk of infection after contact with a
commercial product prepared from inadequately
treated wool or leather (5). Although anthrax has
gradually decreased because of animal vaccination
programs, farmer training, and economical changes,
it is still an endemic zoonosis in Turkey, particularly
in the eastern part (5,7,9-12).
Almost all the reported cases in Turkey are
cutaneous anthrax. All of our cases were also
cutaneous anthrax, and no death occurred. The
disease is commonly seen in people engaged in animal
husbandry and agriculture. While industrialized
cases are associated with industrialized countries,
agricultural cases are the dominant form of infection
in developing countries, such as Turkey (5,7,1214). People are exposed to infectious agent during
operations, such as slaughtering of the animal,
skinning, and cutting of meat. In all of our patients,
except for 2 cases, there was a history of direct
or indirect contact by infected animal or animal
products.
In our study, most of the cases were male, but
there was no significant difference between genders.
In many studies, it has also been reported that there
was no difference in terms of transmission of the
disease between genders (12,15-17). This data is
consistent with our results. However, male or female
predominance has been reported in some studies
(10,14). In our region, animal care, slaughtering,
skinning, meat handling, and processing are
performed by both men and women, which may
be the reason why the disease is distributed equally
among both genders. When we look at the high risk
occupations, farmers and housewives were 91% of
the patients. In the study of Karahocagil et al., farmer
and housewives were 64.7% of the patients while

in the study of Engin et al., they were 89.8% of the
patients (14,15).
The highest risk contacts were cutting of meat
(n = 36, 81.8%) and slaughtering animals (n = 34,
77.3%) in our study. There was the history of direct
contact with sick animals in half of the cases (n = 22,
50%). Our results were similar to the results of other
studies (11,12,15,18,19).
In terms of localization of the lesions, the most
frequent localizations were hands, fingers, and arms
that are in direct contact with sick animal and animal
products. The most common areas of involvement
in our study were hands (54.5%) and arms (50.9%),
which have a high probability to contact with
contaminated product and are relatively open areas.
Eyelids involvement were observed only in 6.8%
of the cases. In the literature, the involved parts of
the body varies according to the region wherein the
study was performed. In the study by Kaya et al.,
previously carried out in our region, hand and arm
involvement were 36.4% and 25.5%, respectively (12).
In a recent study by Engin et al., they found the rate
of patients with hand, arm, and eyelid involvement
as 48.7%, 23.1%, and 20.5%, respectively (14). The
distribution of hands, arms, and eyelids in the study
of Baykam et al. was reported as 39%, 20.6%, and 6.8
percent, respectively (18). The distribution of hand,
arm and face involvement in the study of Demirdağ
et al. was 48%, 28%, and 8%, respectively (19).
Although there have been some areas where eyelids
involvement occurred as the leading area, but hand
and arm involvement are mostly reported in the
cases reported from our country and their results are
similar to our results (12,14,15,18,19).
The seasonal variation in the frequency of the
disease is well known. The number of cases in our
study was increased in August and September.
Animals are infected when they graze on fields or
grain contaminated with spores or through the bites
of flies that have fed on infected carcasses. Heavy
spring rains may serve to concentrate spores into
low-lying area, and if this is followed by a hot, dry
period, animals grazing on these areas with high
spore burdens may become infected (20). Although
animals graze on the field during late spring, whole
summer season and early autumn months in our
region, it is highly possible that contamination risk of
43
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animals increased in August and September, which
relatively have dry weather. The number of cases in
the present study also peaked in 2008. The peak may
be related to the increase of animal anthrax cases in
the same years; however, we have no data supporting
this thesis. In the present study, the WBC count was
more than 10,000/mm3 in 29 patients (65.9%) and
the CRP level was more than 5 mg/L in 42 patients
(95.5%). The elevation of CRP levels in patients with
cutaneous anthrax has been reported previously in
one study and they also found that CRP levels were
higher than 3 mg/L in all patients (11). The data
which were obtained from both studies, showed
the elevation of CRP levels in cutaneous anthrax
cases; but more studies are needed to draw this
conclusion. For the diagnosis of cutaneous anthrax,
first the disase should be suspected. Diagnosis may
be difficult in non-endemic areas. If a patient has a
typical malignant pustule or extensive edema and a
contact history with animals, the diagnosis may be
easy. The patients admitted to our clinic usually had a
history of antibiotic use –especially amoxicillin- prior
to their application. Following 24-48 h of the use of
an active antibiotic against B. anthracis has decreased
the chance of growth of the microorganism from the
cutaneous lesion (5). It is clear that this results in
diagnostic difficulties. History of contact with sick
animals or animal products, and clinical appearance
of the lesions are important data for the diagnosis.
We believe that in addition to the history and
typical clinical appearance, the diagnosis should be
confirmed by detecting the agent in Gram-staining,
the growth of the organism in the culture, or both.
Today, in addition to the conventional diagnostic
methods, serological and molecular methods, such as
ELISA and PCR, have been used. An enzyme-linked
immunosorbent assay (ELISA) for immunoglobulin
G antibodies against B. anthracis protective antigen
in human serum is useful for diagnostic purposes.
The newest diagnostic modality is a polymerase
chain reaction (PCR) (1,14).
Penicillin G is still the drug of choice, and
doxycycline or ciprofloxacin are now accepted as
the best alternatives in the treatment of naturallyoccurring anthrax. World Health Organization
(WHO) guidelines recommend IM procaine penicillin
treatment for 3-7 days in mild uncomplicated
cases of cutaneous anthrax. Intravenous therapy
44

is not recommended in these patients (1,5). As an
alternative, oral penicillin V or amoxicillin for 3-7
days is recommended for the patients who refuse IM
treatment. In patients with life threatening anthrax,
such as inhalational anthrax, gastrointestinal anthrax,
meningoencephalitis, sepsis, or extensive edema
with cutaneous anthrax, antibiotics should be given
intravenously and penicillin G (20-24 million unit
total daily dose) is recommended as the first choice
(1). Both the US CDC and the European guidelines
state that until sensitivities are established the first
line treatment should be ciprofloxacin or doxycycline
with additional 1 or 2 antibiotics from rifampicin,
chloramphenicol, clindamycin, clarithromycin,
erythromycin, gentamicin, streptomycin, or
vancomycin (21-24).
From various regions of the world, albeit in
a small number, in-vitro penicillin resistance in
clinical isolates has been reported (14, 25). In studies
in Turkey penicillin resistance has not been shown
yet (14,26). We selected the treatment modality
according to the patient’s clinical and laboratory
results, and the location and extent of the lesions.
All of the patients in this study were treated with
intravenous or intramuscular penicillin G or with
oral penicillin derivatives. Regarding management,
the lesions were topically covered with gauze
embedded with the topical antiseptic, Rivanol, to
prevent secondary infection. In our patients, none
of the possible complications including secondary
infection, toxemic shock or airway obstruction
were detected and no mortality occurred. Because
no penicillin resistance is shown in our clinical
findings, the findings of other studies, and antibiotic
susceptibility tests clearly indicate that Penicillin G
still has an important place and should be the first
choice in the treatment of cutaneous anthrax in
Turkey.
As a result, although anthrax has decreased
over the years, it is still an important public health
problem in Turkey, especially in the Eastern Anatolia
Region of Turkey. It is easily diagnosed from painless
ulcers, edema and the typical vesicular skin lesions in
endemic areas. In addition, presence of typical history
of contact with animals or animal products provides
important information for diagnosis. Nevertheless,
the recognition of the disease in non-endemic areas
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may be difficult. Early diagnosis and treatment of the
disease is important for prognosis. All clinical forms
may be seen but majority of the cases are cutaneous
anthrax. Clinical presentation of cutaneous anthrax
may be mild or severe, and sometimes leads to severe
complications, such as sepsis, toxemic shock, and

other organ involvement. These clinical forms are
life-threatening complications of cutaneous anthrax.
Early supportive treatment for these complications
with appropriate antimicrobial treatment could be
life-saving.
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